We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen Expands Oncology Portfolio With $10.4 Billion Buy of Onyx
Amgen Expands Oncology Portfolio With $10.4 Billion Buy of Onyx
August 26, 2013
Amgen will acquire Onyx Pharmaceuticals for $10.4 billion in a deal Amgen says will boost its cancer drug portfolio.